WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $25.55, but opened at $26.81. WuXi AppTec shares last traded at $26.81, with a volume of 114 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Strong Buy”.
Check Out Our Latest Research Report on WUXAY
WuXi AppTec Stock Performance
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Featured Articles
- Five stocks we like better than WuXi AppTec
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
